article thumbnail

STAT+: Belgian anti-trust authorities probe Roche for allegedly delaying biosimilars of two cancer meds

STAT

In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.

article thumbnail

Optimizing Your Drug Patent Strategy: A Comprehensive Guide for Pharmaceutical Companies

Drug Patent Watch

Drug patents are a form of intellectual property protection that grants pharmaceutical companies exclusive rights to manufacture, sell, and profit from their innovations for a set period. This exclusivity is the lifeblood of the industry, allowing companies to recoup their substantial R&D investments and fund future discoveries.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: We’re reading about Novo Holdings proceeding with Catalent deal, Sanofi threatened with sanctions, and more

STAT

… Novo Holdings, the parent company of Novo Nordisk, can proceed with its planned $16.5 regulators declined to challenge the deal following months of scrutiny , STAT informs us. The companies expect to close the transaction in the next several days, after a deadline passed for the U.S.

article thumbnail

The Comprehensive Science and Art of Pharmaceutical Drug Naming

Drug Patent Watch

Pharmaceutical drug names are more than just a label - they're a carefully crafted code that conveys essential information about the medication. But what drives this complex system, and how do pharmaceutical companies ensure that their drug names meet the strict guidelines set by regulatory agencies?

article thumbnail

Govt provides update on schemes implemented in the pharma sector

Express Pharma

Once these common facilities are created, they are expected to provide access to common facilities to around 1,300 existing pharmaceutical units, besides catalysing the augmentation of capacities at these clusters through the setting up of new pharmaceutical units and expansion of existing units.

article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. Indian pharmaceutical companies have specialised in reverse-engineering complex medicines and producing biosimilars as alternatives to costly biologics.

article thumbnail

EY Parthenon – OPPI report claims India’s pharma sector set for rapid growth

Express Pharma

Between September and October 2024, EY-P and OPPI undertook primary research * consulting top CXOs from leading Indian and global multinational pharmaceutical companies, to understand their perspective on the pivotal growth areas for the Indian pharma industry.